Collaborations & Alliances
Related Searches:
Filter by:
1 - 15 of 1104 results
June 17, 2013
MedImmune will have the option to license in EEC targets
Read More »
June 17, 2013
Combines HuMax-TAC and PBD-based linker technology for oncology indications
Read More »
June 14, 2013
Will share commercialization, profits and losses
Read More »
June 11, 2013
Recipharm to provide access to Asmasal for Chinese market approval
Read More »
June 3, 2013
Companies plan to explore other partnership opportunities
Read More »
May 29, 2013
Will co-develop five Amgen drugs, form Japan JV
Read More »
May 28, 2013
Will use Cobra’s maxXpress cell line development service
Read More »
May 24, 2013
To develop ZFP therapeutic for blood disease
Read More »
May 24, 2013
Aims to speed up the clinical development process
Read More »
May 22, 2013
To develop drugs to combat bioterrorism and antibiotic resistance
Read More »
May 22, 2013
Will support a Lilly oncology program
Read More »
May 21, 2013
Will use bioreactor technology for large-scale production
Read More »
May 21, 2013
Will combine technologies to optimize nasal spray devices and formulations
Read More »
1 - 15 of 1104 results
